Actually, we found that the CD44-positive subpopulation in primary breast cancer cells (KBr2, KBr3 and KBr4), showed higher levels of AurkA and wnt3a mRNAs as well as increased migratory ability, compared to CD44-negative cells (Fig. 4B). The gene discussed is CD44; the disease is breast carcinoma.